Biosite(R) Incorporated Announces Presentation at William Blair 25th Annual Growth Stock Conference

Biosite(R) Incorporated Announces Presentation at William Blair
25th Annual Growth Stock Conference 


SAN DIEGO, June 17  /PRNewswire-FirstCall/ -- Biosite Incorporated
(NASDAQ:BSTE) today announced that Kim Blickenstaff, Biosite's chairman and
chief executive officer, and Ken Buechler, Ph.D., president and chief
scientific officer, will discuss the Company's operating environment, new and
potential products and the company's research and development activities at the
William Blair 25th Annual Growth Stock Conference.  Biosite's presentation will
take place Wednesday, June 22, 2005, at 3:20 p.m. Eastern.  The conference is
to be held at the Four Seasons Hotel in Chicago.

A link to the live audio webcast and presentation can be accessed through the
Biosite website, http://www.biosite.com/.  The Biosite presentation will be
archived on the website for 21 days in the Investor and Media section under
Events Calendar.

About Biosite Incorporated

Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis.  The Company's
products contribute to improvements in medical care by aiding physicians in the
diagnosis of critical diseases and health conditions. Biosite's Triage(R) rapid
diagnostics are used in approximately 50 percent of U.S. hospitals and in over
50 international markets.  Information on Biosite can be found at
http://www.biosite.com/.

Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated.  The Company's logo is a trademark of
Biosite Incorporated. 

DATASOURCE: Biosite Incorporated



CONTACT:  Nadine Padilla, Vice President, Corporate and Investor

Relations of Biosite Incorporated, [phone], ext. 3187,





Web site:  http://www.biosite.com/ 



Company News On-Call:  http://www.prnewswire.com/comp/116737.html 

Copyright